A plaintiff from Georgia has filed a lawsuit against the drug maker Takeda Pharmaceuticals for alleged development of bladder cancer due to its diabetes controlling drug Actos. According to the lawsuit filed the plaintiff was reported to be named as Marvin C. Ogle a resident of Georgia. The lawsuit was filed by the plaintiff on November 6, 2012 in the Circuit Court of Cook County, Illinois. There are many lawsuits that are lodged and are yet to be heard by plaintiffs who were diagnosed with bladder cancer after taking the medication.

According to the lawsuit, the plaintiff started taking Actos from July 2004 to treat his Type II diabetes and continued it for around 5 years. However, in a recent Cytoscopy test and CT scan it was found that the plaintiff is suffering from bladder cancer. The testing was done on April 26, 2010. In the lawsuit filed by the plaintiff and his Actos attorney it said that the disease forced the plaintiff to undergo a battery of invasive tests and treatments that caused him a lot of financial and mental suffering including a left ureteral stent placement, transurethral resection of the bladder tumor, clot evacuation, a bilateral retrograde pyelogram test and Bacillus Calmate treatments.

In the lawsuit, the plaintiff has accused Takeda of failure to warn patients and medical practitioners about the serious consequences of prolonged use of the drug. The plaintiffs accuse the drug maker of concealing relevant information and for misappropriate representation of the clinical trial data.

Meanwhile, the Actos attorney of the plaintiff has sought tough action against the drug maker and appropriate compensatory and punitive damages for his plaintiff as he suffered all along the way. The lawsuit has brought in a number of counts against the defendant Takeda including failure to warn, misrepresentation, defective design and negligence. In the lawsuit the plaintiff has sought for a monetary compensation of $50,000 and his wife claims loss of consortium.

What is Actos?

Actos is a prescription drug manufactured and marketed by Takeda Pharma, for regulating the level of glucose in the body. The drug is being prescribed across the United States to treat Type II Diabetes Mellitus in adults. The drug Actos is originally called as Pioglitazone that is sold as single-ingredient product under the brand-name Actos.

Some Facts about Actos:

  • The Pioglitazone with the brand name Actos is manufactured and marketed by Takeda Pharma one of the pharmaceutical giants based atNorth America
  • It is estimated that from January 2010 through October 2010, approximately 2.3 million patients filed a prescription for a pioglitazone-containing product.
  • Actos is also sold in combination with metformin and glimepiride
  • The prescription tablet is used along with diet and exercise to regulate the level of blood sugar in adults with type 2 diabetes mellitus.

Why Actos is an unsafe drug?

Recent studies and researches have shown that prolong use of diabetic drug Actos is linked to bladder cancer. The reports have also suggested that Actos is linked to as much as 40 percent increased risk of developing bladder cancer subjected to the duration of the drug consumed.

Some of the signs and symptoms of Actos side effects are:

  • Continuous and unusual pain in shoulder and back region
  • Passage of blood with urine
  • Bloody urine

Acute and increased urge to urinate